semaglutide eligibility across all current indications for us adults What BMI Do You Need to Qualify GLP-1? More than half of all

The dual mechanism of tirzepatide produces greater average weight loss in clinical trials, approximately 22% body weight versus 15% for semaglutide

Muthiah M, Ng CH, Chan KE, Fu CE, Lim WH, Tan DJH, et al

Visit Tonum's research hub to explore clinical data, trial summaries, and fact sheets that can help you evaluate products

The research highlights the potential of semaglutide, the active ingredient in these medications, to serve as a new treatment for alcohol-use disorder, a condition responsible for about 178,000 deaths annually in the United States

Advanced dendritic glucan-derived biomaterials: from molecular structure to versatile applications

Clinical Laboratory Standards Institute